-
Product Insights
Respiratory Distress Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Respiratory Distress Syndrome - Drugs In Development, 2023’, provides an overview of the Respiratory Distress Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Thrombosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Thrombosis - Drugs In Development, 2023’, provides an overview of the Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Acute Respiratory Distress Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Respiratory Distress Syndrome - Drugs In Development, 2023’, provides an overview of the Acute Respiratory Distress Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Respiratory Distress Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Interstitial Lung Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Fibrosis - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Arterial Thrombosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Arterial Thrombosis - Drugs In Development, 2023’, provides an overview of the Arterial Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arterial Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Systemic Sclerosis (Scleroderma) – Drugs In Development, 2023
Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Drugs In Development, 2023’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic Sclerosis (Scleroderma), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Venous (Vein) Thrombosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Venous (Vein) Thrombosis - Drugs In Development, 2023’, provides an overview of the Venous (Vein) Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Venous (Vein) Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Bronchiectasis – Drugs In Development, 2023
Global Markets Direct’s, ‘Bronchiectasis - Drugs In Development, 2023’, provides an overview of the Bronchiectasis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Bronchiectasis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Sector Analysis
Methylene Diphenyl Diisocyanate (MDI) Industry Outlook in India to 2028 – Market Size, Price Trends and Trade Balance
What is covered in the report about the “India Methylene Diphenyl Diisocyanate (MDI) Industry”? GlobalData’s report, “Methylene Diphenyl Diisocyanate (MDI) Industry Outlook in India to 2028 - Market Size, Price Trends and Trade Balance”, provides up to date in-depth information on India’s Methylene Diphenyl Diisocyanate (MDI) industry. The report presents major market trends. The report offers historical and forecast market size, demand and production forecasts, end-use demand details, price trends, trade balance data. *Note: This is an on-demand report and...
-
Sector Analysis
Methylene Diphenyl Diisocyanate (MDI) Industry Outlook in China to 2028 – Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
What is covered in the report about the “China Methylene Diphenyl Diisocyanate (MDI) Industry”? GlobalData’s report, “Methylene Diphenyl Diisocyanate (MDI) Industry Outlook in China to 2028 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants”, provides up to date in-depth information on China’s Methylene Diphenyl Diisocyanate (MDI) industry. The report presents major market trends. The report covers China’s Methylene Diphenyl Diisocyanate (MDI) plants and presents installed capacity by process and technology. The report offers...